Trial Profile
A phase I randomised, repeat patch application study in healthy male volunteers, to determine the pharmacokinetic profile of transdermally delivered oxycodone in combination with the novel penetration enhancer tocopheryl phosphate mix (TPM).
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 02 Feb 2010 Positive results reported in a Phosphagenics media release.
- 02 Feb 2010 Status changed from recruiting to completed, according to a Phosphagenics media release.
- 03 Dec 2009 Status changed from not yet recruiting to recruiting.